NVACW
Profusa, Inc.
Price Chart
No historical data available
Latest Quote
$0.11
-0.01 (-8.33%)
Current Price
| Previous Close | $0.12 |
| Open | $0.10 |
| Day High | $0.12 |
| Day Low | $0.10 |
| Volume | 145,100 |
Stock Information
| Total Debt | $12.54M |
| Cash Equivalents | $375K |
| Net Income | $-36.56M |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Income | $-36.56M |
| Book/sh | $-11.85 |
Financial Ratios
| Quick Ratio | 0.01 |
| Current Ratio | 0.02 |
Returns & Margins
| ROA | -923.19% |
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
| P/B | -0.01 |
Analyst Data
| Recommendation | none |
Technical Indicators
| Shares Float | 4.55M |
| Volatility | 0.32 |
Performance History
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
No history data available. Data will be fetched automatically.
About Profusa, Inc.
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.
đ° Latest News
No news articles available at the moment. Check back later for updates on NVACW.
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.